|
ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
Disclaimer
ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
| Become a Member | ||||
|
||||
Lyrica Found To Be Effective In Reducing Neuropathic Pain In Fibromyalgia Patients, Study Shows
Wednesday 22 November 2017
 |
Lyrica Found to Be Effective in Reducing Neuropathic Pain in Fibromyalgia Patients, Study Shows
Physicians may consider prescribing Lyrica (pregabalin) for fibromyalgia patients who have a primary complaint of neuropathic pain, new research shows.
The study, titled “A comparison of the effectiveness of amitriptilin and pregabalin treatment in fibromyalgia patients,” was published in the journal Northern Clinics of Istanbul.
Fibromyalgia is often treated with non-standardized methods, such as the use of antidepressants, some of which have shown significant effectiveness. One such antidepressant is Elavil (amitriptyline).
Another drug that has shown efficacy in fibromyalgia treatment is Lyrica, marketed by Pfizer. Lyrica was the first drug to be approved by the U.S. Food and Drug Administration for fibromyalgia treatment. Because Lyrica acts independently of antiepileptics, antidepressants, or analgesics, it can be used safely with other drugs.
|
More Fibromyalgia News |
blog comments powered by Disqus
Previous Page |
Registered Charity 3104
Email:
sacfs@sacfs.asn.au
Mailing address:
PO Box 322,
Modbury North,
South Australia 5092
Phone:
1300 128 339
Office Hours:
Monday - Friday,
10am - 4pm
(phone)